Seladelpar lysine is a salt and hydrate form of seladelpar, an orally bioavailable agonist of peroxisome proliferator-activated receptor delta (PPARδ). It is primarily used as an active pharmaceutical ingredient in pharmaceutical manufacturing, with research applications in conditions involving bile acid regulation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 928821-40-3
Seladelpar
pharmaceutical raw material
Elinzanetant
pharmaceutical raw material
Gadoterate meglumine
pharmaceutical raw material
Guaifenesin
pharmaceutical raw material
(RS)-methoxyphenamine
pharmaceutical raw material
(2S)-2,6-diaminohexanoic acid;2-[4-[(2R)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]sulfanyl-2-methylphenoxy]acetic acid;dihydrate
WTKSWPYGZDCUNQ-JZXFCXSPSA-N
CCO[C@H](COC1=CC=C(C=C1)C(F)(F)F)CSC2=CC(=C(C=C2)OCC(=O)O)C.C(CCN)C[C@@H](C(=O)O)N.O.O